Spondyloarthritis & psoriatic arthritis
Arthralgia with risk of progression to psoriatic arthritis: role of clinical assessments and ultrasound as prognostic factors
Authors' conclusion
The frequency of patients ARP-PsA was 8.4%, of whom 29% developed PsA at one year.
Study context
- Population
- Patients with arthralgia in a comprehensive arthralgia evaluation program, not referred from dermatology; ARP-PsA = arthralgia with Pso and/or a family history of Pso
- Participants
- 1,419 patients
- Outcome
- Proportion of ARP-PsA (arthralgia with risk to progression to PsA) among patients with arthralgia
Methodological detailsone-year follow-up, multivariate analysis
- One-year follow-up
- Multivariate analysis
Main finding
As reported in the abstract
Proportion meeting ARP-PsA criteria
Met ARP-PsA criteria
8.4%
Observational data: associations, not effects.
Further findings
Progression to PsA within the ARP-PsA subgroup · one year
- Developed PsA
- 29%
- Predictors on multivariate analysis: Pso plus family history of psoriasis disease, synovitis by Power Doppler US, US enthesopathy findings and low tender joint count
Original publication
Arthralgia with risk of progression to psoriatic arthritis: role of clinical assessments and ultrasound as prognostic factors. Rheumatology (Oxford). Published 15 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →